ResearcherMayo ClinicNo recent work listed
Ayush Sharma
Matched on ORCID iD 0000-0001-5038-1647; OpenAlex author ID A5007797661. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2018: 3 papers · 2019: 1 paper · 2020: 3 papers
Papers 7
- Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus. Co-author DOI 10.1016/j.pan.2020.05.010↗
- Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospe… Co-author DOI 10.1016/j.pan.2020.07.410↗
- Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects First author DOI 10.7326/m19-2336↗
- Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. First author DOI 10.1053/j.gastro.2019.01.039↗
- Risk of Pancreatic Cancer in Patients With Pancreatic Cysts and Family History of Pancreatic Cancer. First author DOI 10.1016/j.cgh.2018.01.049↗
- Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis. Co-author DOI 10.1053/j.gastro.2018.04.025↗
- Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. Co-author DOI 10.1053/j.gastro.2018.05.023↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Suresh T. Chari · 7 shared papers, 2018–2020 · strength 0.72
- Paper Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects DOI 10.7326/m19-2336↗
- Paper Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis. DOI 10.1053/j.gastro.2018.04.025↗
- Paper Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus. DOI 10.1016/j.pan.2020.05.010↗
- Michael J. Levy · 4 shared papers, 2018–2020 · strength 0.34
- Paper Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis. DOI 10.1053/j.gastro.2018.04.025↗
- Paper Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential be… DOI 10.1016/j.pan.2020.07.410↗
- Paper Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2019.01.039↗
- Sajan Jiv Singh Nagpal · 3 shared papers, 2018–2020 · strength 0.26
- Paper Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus. DOI 10.1016/j.pan.2020.05.010↗
- Paper Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. DOI 10.1053/j.gastro.2018.05.023↗
- Paper Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2019.01.039↗
- Naoki Takahashi · 3 shared papers, 2018–2020 · strength 0.24
- Paper Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential be… DOI 10.1016/j.pan.2020.07.410↗
- Paper Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2019.01.039↗
- Paper Risk of Pancreatic Cancer in Patients With Pancreatic Cysts and Family History of Pancreatic Cancer. DOI 10.1016/j.cgh.2018.01.049↗
- Thomas C. Smyrk · 2 shared papers, 2018–2020 · strength 0.21
- Paper Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis. DOI 10.1053/j.gastro.2018.04.025↗
- Paper Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus. DOI 10.1016/j.pan.2020.05.010↗
- Sushil Kumar Garg · 2 shared papers, 2020 · strength 0.20
- Paper Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus. DOI 10.1016/j.pan.2020.05.010↗
- Paper Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential be… DOI 10.1016/j.pan.2020.07.410↗
- Shounak Majumder · 2 shared papers, 2020 · strength 0.20
- Paper Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus. DOI 10.1016/j.pan.2020.05.010↗
- Paper Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential be… DOI 10.1016/j.pan.2020.07.410↗
- Anirban Maitra · 1 shared paper, 2020 · strength 0.19
- Aleksey V. Matveyenko · 2 shared papers, 2019–2020 · strength 0.17
- Paper Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus. DOI 10.1016/j.pan.2020.05.010↗
- Paper Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2019.01.039↗
- Shruti Chandra · 1 shared paper, 2020 · strength 0.10
- Dhruv Pratap Singh · 1 shared paper, 2020 · strength 0.10
- Ajit Harishkumar Goenka · 1 shared paper, 2020 · strength 0.10
- William Arthur Hoos · 1 shared paper, 2018 · strength 0.09
- Gloria M. Petersen · 1 shared paper, 2018 · strength 0.09
- Ziding Feng · 1 shared paper, 2018 · strength 0.09
- Raghuwansh P. Sah · 1 shared paper, 2019 · strength 0.07
- Sneha Vivekanandhan · 1 shared paper, 2019 · strength 0.07
- Naureen Javeed · 1 shared paper, 2019 · strength 0.07
- Debabrata Mukhopadhyay · 1 shared paper, 2019 · strength 0.07
- Mark D. Topazian · 1 shared paper, 2018 · strength 0.07
- Saurabh S. Mukewar · 1 shared paper, 2018 · strength 0.07
- Randall K. Pearson · 1 shared paper, 2018 · strength 0.07
- Santhi Swaroop Vege · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.